---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-025530"
form_type: "8-K"
ticker: "EVFM"
cik: "0001618835"
company_name: "Evofem Biosciences, Inc."
filed_at: "2025-08-26T23:59:59+00:00"
generated_at: "2026-05-17T09:57:26.837574+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Evofem Biosciences amends merger agreement with Aditxt, exchanges $1.573M notes for Series G-1 Preferred Stock

## Summary
- Sixth Amendment to A&R Merger Agreement updated definitions to include Series G-1 Preferred, set dissenting share cap at 5,932,818 common shares and 202 preferred shares.
- Exchanged $1.573M aggregate principal of senior secured convertible notes for 1,573 Series G-1 Preferred shares (stated value $1,000/share, conversion price $0.0154).
- Series G-1 Preferred carries voting rights (as-converted), monthly dividends in stock or PIK, and trigger-event conversion at alternative prices with 25% premium.
- Amendment requires waivers from all Series E-1 Preferred holders on price adjustment and other provisions, and updated exchange agreement for convertible noteholders.
- Merger with Aditxt remains pending; proxy statement to be filed for shareholder vote.

## SEC filing metadata
- accession: 0001641172-25-025530
- form_type: 8-K
- ticker: EVFM
- cik: 0001618835
- company_name: Evofem Biosciences, Inc.
- filed_at: 2025-08-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 5.03, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1618835/000164117225025530/0001641172-25-025530-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1618835/000164117225025530/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-025530
- JSON: https://secwatch.observer/filing/0001641172-25-025530.json
- Plain text: https://secwatch.observer/filing/0001641172-25-025530.txt

## Key facts
- Governance Changes
  Evofem Biosciences, Inc.: Filed Certificate of Designations creating Series G-1 Preferred Stock, amending Articles of Incorporation (effective 2025-08-22).
  - Change: charter amendment
  - Effective: 2025-08-22
  source text: On August 22, 2025 the Company filed the Certificate of Designations creating the Series G-1 Preferred Stock.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1618835/000164117225025530/0001641172-25-025530-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.